Skip to main content
. Author manuscript; available in PMC: 2013 Feb 5.
Published in final edited form as: Pediatr Res. 2012 Feb 15;71(4 Pt 1):332–337. doi: 10.1038/pr.2011.75

Figure 1.

Figure 1

Erythropoietin (Epo) dosing profile. Simulated Epo doses administered to 27 preterm infants optimized to eliminate alloimmune red blood cell transfusions. All simulated epo doses were 600 U/kg intravenous bolus doses. the dosing times for the first and second doses were so close as to effectively represent a double dose. the same is the case for the tenth and eleventh doses.